• 1 Department of Dermatology, The Fourth People’s Hospital, Zigong Sichuan 610041; 2 Department of Pharmacology, West China Hospital, Sichuan University, Chengdu Sichuan 610041,China;
Export PDF Favorites Scan Get Citation

目的:观察口服伊曲康唑治疗皮肤浅部真菌感染的疗效及安全性。方法: 选择200例临床及真菌学确诊皮肤浅部真菌感染患者,分为手足癣和体股癣治疗组。手足癣组口服伊曲康唑200mg,bid;体股癣组口服200mg,qd,均连服7天,停药3周后评价疗效。结果: 手足癣治疗组痊愈率、总有效率和真菌清除率分别为59.38%、82.81%和92%;体股癣治疗组分别为68.06%、87.50%和94%。总不良反应发生率为5.5%。结论: 口服伊曲康唑治疗皮肤浅部真菌病临床疗效好,可靠安全。

Citation: WEI Wennan,ZHU Lan,GU Peng. Oral Itraconazole for Superficial Dermatomycosis: A Clinical Series of 200 Patients. West China Medical Journal, 2009, 24(9): 2354-2355. doi: Copy